INTRODUCTION & OBJECTIVES
Some mild cutaneous conditions do not necessarily deserve a prescription drug as a first line treatment. This is typically the case with dry eczematides for which a healing product may solve the problem with expectations including perfect tolerance, rapid calming effect and quick come back to a mark-free skin across phototypes worldwide. Evidence is growing that to restore skin microbiome plays an important role.
The objective of this study was to evaluate the efficacy and tolerability of a prebiotic-containing healing balm in the management of dry eczematides.